Government Affairs
Refine Search
Pharmaceutical
The price of Swiss pharma giant Novartis’ cancer drug Glivec/Gleevec (imatinib) will now be 44% lower in Colombia than previously, the country’s health authorities have decided. 22 December 2016
Pharmaceutical
Translating bold campaign trail claims of “repeal and replace” into legislative action can often be challenging with any established bill, let alone one as complex as the Affordable Care Act (ACA). 21 December 2016
Pharmaceutical
Sweeping changes are afoot at India's Health Ministry to encourage innovation in the pharmaceutical sector and to ensure speedier approvals for conducting medical research, reports The Pharma Letter's India correspondent. 21 December 2016
Pharmaceutical
The proposed new measures of the Ministry of Health prove to be disastrous for both the right of Greek patients to unhindered and fair access to the necessary treatments and for public health and the viability of the pharmaceutical industry. 19 December 2016
Biotechnology
New York Mayor Bill de Blasio has announced $500 million in funding in a bid to establish the city as a leader in life sciences innovation and research and development (R&D). 14 December 2016
Biosimilars
The 2017 Finance Bill, recently approved by the Republic of Italy's Senate, includes important provisions favoring biosimilar medicines, a significant landmark that will increase competition among biotech drug companies. 14 December 2016
Biotechnology
Australian biotech firm CSL Limited has been announced as a co-investor in the government’s Biomedical Translation Fund, developed to stimulate investment in medical science in Australia. 13 December 2016
Pharmaceutical
The Canadian government has announced new legislation aimed at tackling the growing problem of
opioid drug abuse, citing statistics that record numbers of Canadians have died from drug overdoses this year. 13 December 2016
Pharmaceutical
Rather like Kite’s registrational Zuma-1 trial of KTE-C19 in lymphoma, Novartis’ Eliana study has generated a fileable response rate. In the case of the Swiss firm’s rival CAR-T therapy, CTL019, this is in childhood leukemia patients, says EP Vantage, the editorial arm of the Evaluate group. 10 December 2016
Pharmaceutical
A wide-ranging bill promising to fund biomedical research, establish a council to speed up the discovery, development, and delivery of innovative medicines and advance precision medicine, has been passed in the US Senate. 8 December 2016
Pharmaceutical
Global drugmakers operating their plants in Russia have criticized the latest state initiative to introduce new restrictions on the participation of foreign drug manufacturers in tenders for the public procurement of drugs for state needs, reports The Pharma Letter’s local correspondent. 6 December 2016
Pharmaceutical
Legislation introduced to Parliament on the final sitting day of 2016 will enable faster access to certain new medicines for Australian patients and help to cut unnecessary red tape for industry too. 2 December 2016
Pharmaceutical
US President-elect Donald Trump has chosen a fierce critic of the Affordable Care Act and a proponent of overhauling the nation’s entitlement programs, to lead the Department of Health and Human Services. 30 November 2016
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has welcomed the three main economic objectives of a strategy on what more can be done to support growth, reinforce economic convergence, create jobs and strengthen social fairness in European Union (EU) countries. 28 November 2016
Biosimilars
Trade group Medicines for Europe, which represents the generics and biosimilars sector, has taken issue with the report ‘Health at a Glance 2016’ launched yesterday prepared by the Organization for Economic Co-operation and Development (OECD) for the European Commission. 28 November 2016
Pharmaceutical
The Russian government has designed new restrictions for the participation of foreign drugmakers in state tenders for the purchase of drugs for state needs, reports The Pharma Letter’s local correspondent. 25 November 2016
Pharmaceutical
Trade group the Association of the British Pharmaceutical Industry (ABPI) has welcomed the likely impact of the UK Chancellor’s Autumn Statement on the sector. 23 November 2016
Generics
Even as Astellas Pharma and Pfizer have received the green signal on a supplemental New Drug Application from the US Food and Drug Administration for Xtandi (enzalutamide) to treat advanced prostate cancer, the Indian patent office has denied Xtandi a patent, opening up the market to generic versions of the drug, reports The Pharma Letter’s India correspondent. 23 November 2016
Biotechnology
The US trade group the Biotechnology Innovation Organization, has declared its disappointment in Japan's price modification of innovative drugs undermining predictable system. 23 November 2016
Biotechnology
The proposed A$2 million cap on the R&D Tax Incentive will seriously damage clinical trials activity in Australia, should the Federal government proceed with the measure, says the trade group AugBiotech. 22 November 2016
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze